Related Experiment Video
Updated: Aug 4, 2026

07:51
Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
Published on: January 13, 2012
Computer simulation to estimate the effectiveness of carotid endarterectomy
1Newcastle and North Tyneside Health Authority, UK.
Journal of Health Services Research & Policy
|December 8, 1997
Summary
Carotid endarterectomy offers a modest benefit in quality-adjusted life months for patients after transient ischaemic attacks. However, this surgical intervention is unlikely to be cost-effective for many UK patient groups.
Area of Science:
- Neurology
- Health Economics
- Medical Decision Making
Background:
- Transient ischaemic attacks (TIAs) are critical warning signs for stroke.
- Carotid endarterectomy (CEA) is a surgical procedure to reduce stroke risk.
- Evaluating the comparative effectiveness and cost-effectiveness of CEA versus medical management is crucial for patient care.
Purpose of the Study:
- To assess the benefit of carotid endarterectomy (CEA) compared to medical treatment for patients experiencing transient ischaemic attacks (TIAs).
- To analyze outcomes across diverse patient subgroups to understand differential benefits.
Main Methods:
- A Markov model was employed to simulate patient survival and quality of life.
- Quality-adjusted life months (QALMs) were used as the primary measure of benefit.
- Computer simulations utilized published data on event probabilities, with sensitivity analyses performed.
Main Results:
- The baseline model indicated a 3 QALM benefit for CEA in a 65-year-old male patient.
- Sensitivity analysis revealed potential benefits ranging from 13.4 QALMs to a loss of 2 QALMs.
- Approximately 80% of simulated factor combinations favored surgery, while 15.6% favored medical treatment.
Conclusions:
- Computer simulations can estimate treatment benefits for specific patient groups using clinical trial data.
- This simulation suggests CEA is unlikely to be cost-effective in the UK for many TIA patients, despite stroke risk reduction.
- Further integration with cost data can refine cost-effectiveness analyses for personalized treatment decisions.

